Interaction of zinc with antidepressants in the tail suspension test

Bancila, 2004, Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus, J Neurochem, 90, 1243, 10.1111/j.1471-4159.2004.02587.x Barañano, 2001, Atypical neural messengers, Trends Neurosci, 24, 99, 10.1016/S0166-2236(00)01716-1 Berton, 2006, New approaches to antidepressant drug discovery: beyond monoamines, Nat Rev Neurosci, 7, 137, 10.1038/nrn1846 Borsini, 1988, Is the forced swimming test a suitable model for revealing antidepressant activity?, Psychopharmacology, 94, 147, 10.1007/BF00176837 Brocardo, 2007, Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain, Toxicol Sci, 97, 140, 10.1093/toxsci/kfm024 Brocardo, 2008, Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems, Neuropharmacology, 54, 464, 10.1016/j.neuropharm.2007.10.016 Brunello, 2002, The role of noradrenaline and selective noradrenaline reuptake inhibition in depression, Eur Neuropsychopharmacol, 12, 461, 10.1016/S0924-977X(02)00057-3 Carrodi, 1968, The effects of imipramine on central monoamine neurones, J Pharm Pharmacol, 20, 230, 10.1111/j.2042-7158.1968.tb09727.x Choi, 1998, Zinc and brain injury, Annu Rev Neurosci, 21, 347, 10.1146/annurev.neuro.21.1.347 Cieślik, 2007, Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats, Pharmacol Rep, 59, 46 Cooper, 1980, Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo, J Pharmacol Exp Ther, 215, 127 D'Aquila, 2000, The role of dopamine in the mechanism of action of antidepressant drugs, Eur J Pharmacol, 405, 365, 10.1016/S0014-2999(00)00566-5 DeBattista, 2006, Augmentation and combination strategies for depression, J Psychopharmacol, 20, 11, 10.1177/1359786806064310 Dhillon, 2008, Bupropion: a review of its use in the management of major depressive disorder, Drugs, 68, 653, 10.2165/00003495-200868050-00011 Dhir, 2007, Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor, Eur J Pharmacol, 568, 177, 10.1016/j.ejphar.2007.04.028 Dwoskin, 2006, Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent, CNS Drug Rev, 12, 178, 10.1111/j.1527-3458.2006.00178.x Frederickson, 1983, Cytoarchitectonic distribution of zinc in the hippocampus of man and rat, Brain Res, 273, 335, 10.1016/0006-8993(83)90858-2 Frederickson, 2000, Importance of zinc in the central nervous system: the zinc-containing neuron, J Nutr, 130, 1471S, 10.1093/jn/130.5.1471S Garcia, 2008, Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus, Prog Neuro-Psychopharmacol Biol Psychiatry, 32, 140, 10.1016/j.pnpbp.2007.07.027 Glowinski, 1964, Inhibition of uptake of tritiated noradrenaline in intact rat brain by imipramine and structurally related compounds, Nature, 204, 1318, 10.1038/2041318a0 Gould, 2006, Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders, Curr Drug Targets, 7, 1399, 10.2174/1389450110607011399 Harrison, 1994, Zn: an endogenous modulator of ligand- and voltage-gated ion channels, Neuropharmacology, 33, 935, 10.1016/0028-3908(94)90152-X Hyttel, 1994, Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs), Int Clin Psychopharmacol, 9, 19, 10.1097/00004850-199403001-00004 Ilouz, 2002, Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc, Biochem Biophys Res Commun, 295, 102, 10.1016/S0006-291X(02)00636-8 Itil, 1983, A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression, Br J Clin Pharmacol, 15, 433S, 10.1111/j.1365-2125.1983.tb02134.x Kroczka, 2000, Zinc exhibits an antidepressant-like effect in the forced swimming test in mice, Pol J Pharmacol, 52, 403 Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Res Bull, 55, 297, 10.1016/S0361-9230(01)00473-7 MacGillivray, 2003, Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis, BMJ, 326, 1014, 10.1136/bmj.326.7397.1014 Machado, 2007, Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system, Prog Neuro-Psychopharmacol Biol Psychiatry, 31, 421, 10.1016/j.pnpbp.2006.11.004 Maeng, 2008, Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors, Biol Psychiatry, 63, 349, 10.1016/j.biopsych.2007.05.028 Maes, 1994, Hypozincemia in depression, J Affect Disord, 31, 135, 10.1016/0165-0327(94)90117-1 Maes, 1997, Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biol Psychiatry, 42, 349, 10.1016/S0006-3223(96)00365-4 Maes, 1999, Lower serum zinc in major depression in relation to changes in serum acute phase proteins, J Affect Disord, 56, 189, 10.1016/S0165-0327(99)00011-7 Maj, 1992, Effects of MK-801 and antidepressant drugs in the forced swimming test in rats, Eur Neuropsychopharmacol, 2, 37, 10.1016/0924-977X(92)90034-6 Manser, 1989, Trace element studies on Karachi population. Part IV: blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders, J Pak Med Assoc, 39, 269 McLoughlin, 1990, Zinc in depressive disorder, Acta Psychiatr Scand, 82, 451, 10.1111/j.1600-0447.1990.tb03077.x Mittal, 1995, Interaction of heavy metal toxicants with brain constitutive nitric oxide synthase, Mol Cell Biochem, 149–150, 263, 10.1007/BF01076586 Molnár, 2001, Synaptically-released zinc inhibits N-methyl-aspartate receptor activation at recurrent mossy fiber synapses, Brain Res, 910, 205, 10.1016/S0006-8993(01)02720-2 Musselman, 1998, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment, Arch Gen Psychiatry, 55, 580, 10.1001/archpsyc.55.7.580 Nelson, 1991, Current status of tricyclic antidepressants in psychiatry: their pharmacology and clinical applications, J Clin Psychiatry, 52, 193 Nelson, 2007, Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies, CNS Spectr, 12, 6, 10.1017/S1092852900016011 Nestler, 2006, The mesolimbic dopamine reward circuit in depression, Biol Psychiatry, 59, 1151, 10.1016/j.biopsych.2005.09.018 Nestler, 2002, Neurobiology of depression, Neuron, 34, 13, 10.1016/S0896-6273(02)00653-0 Nemeroff, 2007, The burden of severe depression: a review of diagnostic challenges and treatment alternatives, J Psychiatr Res, 41, 189, 10.1016/j.jpsychires.2006.05.008 Nowak, 2001, Does interaction between zinc and glutamate system play a significant role in the mechanism of antidepressant action?, Acta Pol Pharm Drug Res, 58, 73 Nowak, 2002, Mechanisms contributing to antidepressant zinc action, Pol J Pharmacol, 54, 587 Nowak, 2005, Zinc and depression. An update, Pharmacol Rep, 57, 713 Nowak, 2003, Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study, Pol J Pharmacol, 55, 1143 Nowak, 2003, Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats, Brain Res Bull, 61, 159, 10.1016/S0361-9230(03)00104-7 Nowak, 1999, Serum trace elements in animal models and human depression, Part I. Zinc. Hum. Psychopharmacol Clin Exp, 14, 83, 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.0.CO;2-6 Papakostas, 2007, Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials, J Clin Psychiatry, 68, 1907, 10.4088/JCP.v68n1211 Papakostas, 2004, Quality of life assessments in major depressive disorder: a review of the literature, Gen Hosp Psych, 26, 13, 10.1016/j.genhosppsych.2003.07.004 Peters, 1987, Zinc selectively blocks the action of N-methyl-d-aspartate on cortical neurons, Science, 236, 589, 10.1126/science.2883728 Rabkin, 1999, Effects of fluoxetine on mood and immune status in depressed patients with HIV illness, J Clin Psychiatry, 55, 92 Richelson, 2003, Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance, J Clin Psychiatry, 64, 5 Richelson, 1984, Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake, Eur J Pharmacol, 104, 277, 10.1016/0014-2999(84)90403-5 Rodrigues, 2002, Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus, Life Sci, 70, 1347, 10.1016/S0024-3205(01)01498-9 Rogóz, 2002, Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats, Neuropharmacology, 42, 1024, 10.1016/S0028-3908(02)00055-2 Rogóz, 2004, Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies, Pol J Pharmacol, 56, 179 Rosa, 2003, Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice, Behav Brain Res, 144, 87, 10.1016/S0166-4328(03)00069-X Rosa, 2008, Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice, Prog Neuro-Psychopharmacol Biol Psychiatry, 32, 1549, 10.1016/j.pnpbp.2008.05.020 Rush, 2003, Depression, IV: STAR⁎D treatment trial for depression, Am J Psychiatry, 160, 237, 10.1176/appi.ajp.160.2.237 Schlegel-Zawadzka, 2000, Effect of depression and of antidepressant therapy on serum zinc levels — a preliminary clinical study, 607 Simon, 1995, Research diagnosis of current depressive disorder: a comparison of methods using current symptoms and lifetime history, J Psychiatry Res, 29, 457, 10.1016/0022-3956(95)00026-7 Skolnick, 1992, Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-d-aspartate receptor complex, Psychopharmacology, 107, 489, 10.1007/BF02245261 Sleath, 2003, Drug information sources and antidepressant adherence, Community Ment Health J, 39, 359, 10.1023/A:1024080410284 Smart, 1994, Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc, Prog Neurobiol, 42, 393, 10.1016/0301-0082(94)90082-5 Stahl, 2004, Selectivity of SSRIs: individualising patient care through rational treatment choices, Int J Psychiatry Clin Pract, 8, 3, 10.1080/13651500410005487 Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Szewczyk, 2002, Interaction of zinc with antidepressants in the forced swimming test in mice, Pol J Pharmacol, 54, 681 Takeda, 2000, Movement of zinc and its functional significance in the brain, Brain Res Bull, 34, 137, 10.1016/S0165-0173(00)00044-8 Thase, 2001, The clinical, psychosocial, and pharmacoeconomic ramifications of remission, Am J Manag Care, 7, S377 Trullas, 1990, Functional antagonists of the NMDA receptor complex exhibit antidepressant action, Eur J Pharmacol, 185, 1, 10.1016/0014-2999(90)90204-J Trullas, 1991, 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models, Eur J Pharmacol, 203, 379, 10.1016/0014-2999(91)90894-V Wong, 2001, Research and treatment approaches to depression, Nat Rev Neurosci, 2, 343, 10.1038/35072566 Yeh, 1990, Evidence that zinc inhibits N-methyl-d-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding, Mol Pharmacol, 38, 14